Increased transmembrane protein 119 (TMEM119) levels in the cerebrospinal fluid of patients with mild cognitive impairment due to Alzheimer's disease suggest early microglial involvement

Paula Klassen, Christoforos Alexudis, Veronika Klose, Nerea Gómez de San José, André Huss, Franziska Bachhuber, Önder Soylu, Badrieh Fazeli, Deborah Erhart, Mona Laible, Sarah Anderl‐Straub, Sarah Jesse, Markus Otto, Albert C. Ludolph, Hayrettin Tumani, Steffen Halbgebauer

Open source

DOI: 10.1002/dad2.70240
Published: 2025-12-31
Container: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/dad2.70240,
  title = {Increased transmembrane protein 119 (TMEM119) levels in the cerebrospinal fluid of patients with mild cognitive impairment due to Alzheimer's disease suggest early microglial involvement},
  author = {Paula Klassen and Christoforos Alexudis and Veronika Klose and Nerea Gómez de San José and André Huss and Franziska Bachhuber and Önder Soylu and Badrieh Fazeli and Deborah Erhart and Mona Laible and Sarah Anderl‐Straub and Sarah Jesse and Markus Otto and Albert C. Ludolph and Hayrettin Tumani and Steffen Halbgebauer},
  year = {2025},
  journal = {Alzheimer's \&amp; Dementia: Diagnosis, Assessment \&amp; Disease Monitoring},
  doi = {10.1002/dad2.70240},
  url = {https://doi.org/10.1002/dad2.70240}
}

RIS

TY  - JOUR
TI  - Increased transmembrane protein 119 (TMEM119) levels in the cerebrospinal fluid of patients with mild cognitive impairment due to Alzheimer's disease suggest early microglial involvement
AU  - Paula Klassen
AU  - Christoforos Alexudis
AU  - Veronika Klose
AU  - Nerea Gómez de San José
AU  - André Huss
AU  - Franziska Bachhuber
AU  - Önder Soylu
AU  - Badrieh Fazeli
AU  - Deborah Erhart
AU  - Mona Laible
AU  - Sarah Anderl‐Straub
AU  - Sarah Jesse
AU  - Markus Otto
AU  - Albert C. Ludolph
AU  - Hayrettin Tumani
AU  - Steffen Halbgebauer
PY  - 2025
JO  - Alzheimer's &amp; Dementia: Diagnosis, Assessment &amp; Disease Monitoring
DO  - 10.1002/dad2.70240
UR  - https://doi.org/10.1002/dad2.70240
ER  -

APA

Klassen, P., Alexudis, C., Klose, V., José, N. G. D. S., Huss, A., Bachhuber, F., Soylu, Ö., Fazeli, B., Erhart, D., Laible, M., Anderl‐Straub, S., Jesse, S., Otto, M., Ludolph, A. C., Tumani, H., & Halbgebauer, S. (2025). Increased transmembrane protein 119 (TMEM119) levels in the cerebrospinal fluid of patients with mild cognitive impairment due to Alzheimer's disease suggest early microglial involvement. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. https://doi.org/10.1002/dad2.70240

Source records

crossref · retrieved 2026-09-27T04:23:50.355Z